MedPath

Comparison of two different drugs as Adjuvants in spinal anesthesia for Abdominal Hysterectomy surgeries.

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/01/039437
Lead Sponsor
PUSHPAGIRI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE
Brief Summary

Patients planned for elective procedures will be approached prior to the study and patient information sheet  will be given

Pre-anaesthetic checkup will be done on the day before surgery.

An informed consent will be taken, and patient will be kept nil per oral for 6 hours prior to surgery.

Premedication with T. Pantoprazole 40mg, T. Metoclopramide 10mg and T. Alprazolam 0.25mg will be given  on  the previous night and in the morning.

The visual analogue system will be explained to all patients.

IV access will be secured before the procedure. Preloaded with ringer lactate 500ml.

Vital parameters will be monitored before and during the surgery using pulse oximetry, BP , continuous ECG,  etc.

Baseline hemodynamic parameters will be measured (SBP, MAP, HR, DBP)

Inj. Ondansetron(4mg) and Inj. Midazolam(1 mg) will be administered IV 15 minutes prior to surgery.

Spinal anaesthesia to be administered with the patients in left lateral position at L3L4 space with 23-25 gauge spinal needle.

The drug to be loaded and handed over by one person not related to the study.



Group 1-patients to receive 0.5% bupivacaine 3ml with 0.5ml (25µg) fentanyl

Group 2- patients to receive 0.5% bupivacaine 3ml with 0.5ml (10µg) dexmedetomidine

intraoperatively monitoring of blood pressure, pulse rate and saturation done at 5,10,15,20,25 and 30min after injection and subsequently every 15 min.

 

Onset of sensory blockade and onset of complete motor blockade to be recorded

Sensory block assessed by pinprick method

motor block assessed by Modified Bromage scale

Duration of sensory and motor blockade to be noted

Postoperatively pain score(VAS) assessed at 1hr for first 4h and at 6,12and24h; rescue analgesics will be given when VAS score is more than 4 or on patient request for pain relief; duration of analgesia to be noted.

Any fall in heart rate below 50/min to be treated with atropine 0.6mg

Fall in systolic blood pressure below 20% of the baseline to be managed with inj. Ephedrine 6 mg in increments.

Any signs of respiratory depression noted to be dealt with oxygen supplementation and assisted ventilation.

Data collected will be entered on study proforma

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

PATIENTS OF ASA STATUS 1 & 2.

Exclusion Criteria

1.PATIENT REFUSAL 2.PATIENT ON ALPHA BLOCKERS, BETA BLOCKERS DRUGS 3.PATIENT SENSITIVE OR ALLERGIC TO STUDY MEDICATIONS 4.PATIENTS OF ASA STATUS 3 & 4.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TIME OF RESCUE ANALGESIAVAS SCORE ASSESSED AT 1hr 2hr 3hr 4hr 6hr 12hr 24hr | RESCUE ANALGESIA GIVEN WHEN VAS SCORE MORE THAN 4 OR ON PATIENT REQUEST | TIME IN MINUTES NOTED | DURATION OF ANALGESIA NOTED
Secondary Outcome Measures
NameTimeMethod
TIME OF ONSET OF SENSORY BLOCKBY PIN PRICK METHOD
HEART RATE5,10,15,20,25 and 30min after injection and subsequently every 15 min.
TIME OF ONSET OF MOTOR BLOCKBY MODIFIED BROMAGE SCALE
SPO25,10,15,20,25 and 30min after injection and subsequently every 15 min.
DURATION OF SENSORY BLOCKGRADE 2 ON PIN PRICK
DURATION OF MOTOR BLOCKMODIFIED BROMAGE SCALE SCORE 0
SYSTOLIC AND DIASTOLIC BLOOD PRESSURE5,10,15,20,25 and 30min after injection and subsequently every 15 min.

Trial Locations

Locations (1)

PUSHPAGIRI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE

🇮🇳

Pathanamthitta, KERALA, India

PUSHPAGIRI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE
🇮🇳Pathanamthitta, KERALA, India
VIJITHA BABY
Principal investigator
9446801383
vijithababy10@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.